Global Patent Index - EP 3720871 A1

EP 3720871 A1 20201014 - TARGETED IMMUNOTOLERANCE

Title (en)

TARGETED IMMUNOTOLERANCE

Title (de)

GEZIELTE IMMUNTOLERANZ

Title (fr)

IMMUNOTOLÉRANCE CIBLÉE

Publication

EP 3720871 A1 20201014 (EN)

Application

EP 18887096 A 20181128

Priority

  • US 201762595348 P 20171206
  • US 201762595357 P 20171206
  • US 201815988311 A 20180524
  • US 201862675972 P 20180524
  • US 2018034334 W 20180524
  • US 201816109875 A 20180823
  • US 201816109897 A 20180823
  • US 201862721644 P 20180823
  • US 2018062780 W 20181128

Abstract (en)

[origin: WO2019112852A1] Methods and compounds for conferring site-specific or local immune privilege.

IPC 8 full level

C07K 14/55 (2006.01); A61K 38/00 (2006.01); C07K 19/00 (2006.01)

CPC (source: EP)

C07K 14/55 (2013.01); C07K 14/70503 (2013.01); C07K 14/70532 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/31 (2013.01); C07K 2319/33 (2013.01)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2019112852 A1 20190613; EP 3720871 A1 20201014; EP 3720871 A4 20210915; JP 2021505156 A 20210218

DOCDB simple family (application)

US 2018062780 W 20181128; EP 18887096 A 20181128; JP 2020531046 A 20181128